News

Na Presseportal17y
New Powerful Antihypertensive MicardisPlus(R) 80/25 (80mg telmisartan/25mg hydrochlorothiazide) Approved by EU Commission - Presseportal
New Powerful Antihypertensive MicardisPlus(R) 80/25 (80mg telmisartan/25mg hydrochlorothiazide) Approved by EU Commission Ingelheim, Germany (ots/PRNewswire) - For Medical Media, Outside the US Only ...
Yahoo Finance4y
Global Telmisartan Market By Indication, By Distribution Channel, By Regional Outlook, Industry Analysis Report and Forecast, 2020 - 2026 - Yahoo Finance
Aug-2017: Zydus Cadila received approval from the USFDA to market Telmisartan and Hydrochlorothiazide Tablets USP, in the dosage of 40 mg/12.5 mg, 80mg/12.5 mg, and 80mg/25 mg. Telmisartan and ...
Nature16y
Effect of switching from amlodipine to combination therapy with telmisartan and low-dose hydrochlorothiazide
In fact, the addition of low-dose hydrochlorothiazide doubled the antihypertensive effect of losartan. 16 Similarly, hydrochlorothiazide greatly enhances the BP depressor effects of telmisartan ...
Indiatimes11y
Optidoz is a single pill combination of three anti-hypertensive drugs (Amlodipine 2.5 mg, Telmisartan 20mg and Hydrochlorothiazide 6.25mg) with optimal (half ... - Times of India
Home News: Times of India brings the Latest & Top Breaking News on Politics and Current Affairs in India & around the World, Cricket, Sports, Business, Bollywood News and Entertainment, Science ...
Nature8y
Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized ...
The efficacy and safety of telmisartan 80 mg/amlodipine 5 mg plus hydrochlorothiazide 12.5 mg (T80/A5/H12.5) was examined for its ability to treat hypertension in Japanese patients whose ...
Europa Press17y
New Powerful Antihypertensive MicardisPlus(R) 80/25 (80mg telmisartan/25mg hydrochlorothiazide) Approved by EU Commissio - Europa Press
Boehringer Ingelheim today announced that the European Commission has granted marketing authorisation of the new powerful strength of their fixed dose combination antihypertensive drug ...